A carregar...
Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man.
Prostacyclin (PGI2) is an inhibitor of platelet function in vitro. We tested the hypothesis that PGI2 is formed in biologically active concentrations at the platelet-vascular interface in man and can be pharmacologically modulated to enhance its inhibitory properties. This became feasible when we de...
Na minha lista:
| Publicado no: | J Clin Invest |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
1989
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC303692/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2643628/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI113895 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|